NICOLE VITRONE: Open Payments
NPI 1558046037 · POMPTON PLAINS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 52 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $562 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $181 |
| Corcept Therapeutics | 8 | $146 |
| UCB, Inc. | 4 | $88 |
| ABBVIE INC. | 4 | $67 |
| Novo Nordisk Inc | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: RECORLEV, Korlym, Fintepla, Kerendia, Veozah, Wegovy, DUPIXENT, EVENITY.
Industry payments across NJ — which companies pay providers there.
